Breast Cancer Coverage from Every Angle

Youssef Zeidan, MD, PhD: Expert Perspective on Radiotherapy and Treatment-Related Cardiotoxicity in Breast Cancer

Posted: Thursday, December 2, 2021

Youssef Zeidan, MD, PhD, of Florida International University and the Lynn Cancer Institute, discusses the ways in which radiotherapy has improved to reduce cardiotoxicity in patients treated with trastuzumab for HER2-positive breast cancer.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.